Independent Director · BeOne Medicines Ltd. (ONC)

Corazon (Corsee) D. Sanders — BeOne Medicines Director Compensation (2025)

Fiscal year 2025 director compensation for Corazon (Corsee) D. Sanders at BeOne Medicines Ltd.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Corazon (Corsee) D. Sanders’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Corazon (Corsee) D. Sanders and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

BeOne Medicines Director Compensation Table · the one fiscal year held
In US dollars, as BeOne Medicines reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$102,500$199,834$199,954$0$502,288

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BeOne Medicines Ltd. DEF 14A filed April 28, 2026, accession 0001104659-26-049655, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BeOne Medicines Ltd. filed document, accession 0001104659-26-049655. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the BeOne Medicines Board Governance Report

$502,288 Corazon (Corsee) D. Sanders, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

BeOne Medicines pays directors a $65,000 cash retainer and $400,000 in equity.

Committees

FY2025 · as the proxy prints them

Audit · Scientific Advisory · Commercial and Medical Affairs Advisory

The rest of the BeOne Medicines board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alessandro RivaIndependent Director$494,788
Anthony C. HooperIndependent Director$528,129
Charles L. SawyersIndependent Director—
Elizabeth F. MooneyIndependent Director—
Felix J. BakerIndependent Director—
John V. OylerChair of the Board—
Margaret DuganIndependent Director$514,788
Michael GollerIndependent Director$484,788
Olivier BrandicourtIndependent Director$492,288
Qingqing YiIndependent Director$489,788
Ranjeev KrishanaIndependent Director$489,788
Shalini SharpIndependent Director$525,165
Xiaodong WangDirector$4,249,830

The full BeOne Medicines compensation record

free company brief

This page is one director within BeOne Medicines's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the BeOne Medicines proxy · each links to its own free brief

Order ONC

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report